The Board of Directors of Novozymes A/S at the Annual Shareholders' Meeting to be held on March 3, 2023, intends to propose a dividend payment of DKK 6.00 per share for a total payout of approximately DKK 1,660 million for the 2022 financial year. This is 9%, or DKK 0.50, higher per share than the dividend paid for 2021 and corresponds to a payout ratio of 45.0% of the net profit generated in 2022. Adjusted for non-recurring items with no cash flow impact related to 21st.Bio and the Microbiome Labs earnout, the payout ratio is 50.9%.

If approved, the 2022 dividend will be disbursed on March 7, 2023, with March 2, 2023, as the last trading day with dividend for 2022.